Intermittent Preventive Treatment for Malaria During Pregnancy
Author Information
Author(s): Briand Valérie, Cottrell Gilles, Massougbodji Achille, Cot Michel
Primary Institution: Mother and Child Health in the Tropics (UR010), Development Research Institute (IRD), Paris, France
Hypothesis
How can intermittent preventive treatment (IPTp) be optimized for malaria prevention during pregnancy in high transmission areas?
Conclusion
IPTp with sulphadoxine-pyrimethamine is currently the most effective strategy for preventing malaria during pregnancy, but improvements in implementation and alternative treatments are urgently needed.
Supporting Evidence
- Malaria in pregnancy is a major cause of maternal morbidity and adverse birth outcomes.
- IPTp has been shown to be effective in preventing low birth weight and severe maternal anaemia.
- Resistance to sulphadoxine-pyrimethamine is growing, necessitating the evaluation of alternative drugs.
Takeaway
This study talks about giving pregnant women medicine to prevent malaria, especially in areas where malaria is common. It suggests that we need to make sure more women get this medicine and look for better options as some medicines are becoming less effective.
Methodology
The paper reviews existing data on the efficacy of IPTp and discusses strategies for improving its implementation.
Potential Biases
Potential biases in studies due to non-randomized dosing based on women's attendance at antenatal care visits.
Limitations
The study highlights that the optimal number of doses and timing for IPTp administration have not been clearly established.
Participant Demographics
The study focuses on pregnant women in high malaria transmission areas, particularly in sub-Saharan Africa.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website